Recent advances in cancer diagnostics

Lung cancer is the third most common cancer in the UK, after breast and prostate cancer, and is responsible for over 35,000 deaths per year. Over the past decade, huge strides have been made in terms of survival and because of the burden of this disease the need for improved diagnostics and access to therapies is greater than ever to optimise the quality of life for lung cancer patients.

This story is Premium Content and is only available to registered users. If you don't already have an account, please register with us completely free of charge.

Other news

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $20 billion and more than 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics...

Learn more »